Skip to main content

Table 3 Correlations between TGF-β1 and other parameters

From: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

  CHC N = 36 FL N = 45 NASH N = 42
CRP ND TGF-β1 TGF-β1
   r = 0.37 r = 0.29
   P = 0.08 P = 0.055
ALT TGF-β1 TGF-β1 TGF-β1
  r = -0.02 r = -0.13 r = -0.34
  P = 0.9 P = 0.38 P = 0.026
BMI TGF-β1 TGF-β1 TGF-β1
  rho = 0.13 rho = 0.18 rho = 0.09
  P = 0.46 P = 0.22 P = 0.56
US score ND TGF-β1 TGF-β1
   rho = -0.08 rho = 0.05
   P = 0.57 P = 0.72
Fibrosis score TGF-β1 ND TGF-β1
  rho = -0.09   rho = 0.05
  P = 0.60   P = 0.75
Age TGF-β1 TGF-β1 TGF-β1
  r = -0.02 r = 0.02 r = -0.009
  P = 0.9 P = 0.9 P = 0.9
  1. CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; US score, hepatic steatosis score at ultrasound; r, Pearson's correlation coefficient and rho, Spearman's rank correlation coefficient, chosen according to the variable distribution (normal or not normal as well as being ordinals, respectively); ND, not determined.